Rahmer Peter's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Jul 2, 2026
- Accession no.
- 0001193125-26-294528
- Filed
- Jul 2, 2026, 4:12 PM ET
- Trade date
- Jun 30, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $954.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rahmer PeterCIK 0001959229 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | SSaleDisposed | −50,000 | $19.09 | −$954,500 | 225,857 | Direct | |
| Jun 30, 2026 | Common Stock | AGrant or awardAcquired | +3,056 | $6.95 | +$21,239.2 | 228,913 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.